CO1 Comparative Efficacy of Non-Statin Lipid-Lowering Therapies in Patients With Hypercholesterolemia at Increased Cardiovascular Risk: An Updated Network Meta-Analysis
Heather Burnett, R. Jindal(Novartis (Switzerland)), Allie Cichewicz(Ithaka Harbors), K. Buesch(BH Consulting (Ireland)), Andreas Reichelt(Novartis (Switzerland)), D. Bhowmik(Novartis (India)), Binod Neupane(Public Health Agency of Canada), H. Natani(Novartis (India)), V. Pierre(University of North Carolina at Chapel Hill), Kyle Fahrbach(Institut de Biologie systémique et synthétique)
Cited by 0
Related Papers
Prognosis after West Nile Virus Infection
|Annals of Internal Medicine|2008|58
Identification and Mapping Real-World Data Sources for Heart Failure, Acute Coronary Syndrome, and Atrial Fibrillation
|Cardiology|2021|15
Population Pharmacokinetics of Morphine in Patients With Nonalcoholic Steatohepatitis (NASH) and Healthy Adults
|CPT Pharmacometrics & Systems Pharmacology|2017|11
Comparative Efficacy of Nonstatin Lipid-Lowering Therapies in Patients With Hypercholesterolemia at Increased Cardiovascular Risk: An Updated Network Meta-Analysis
|Journal of Cardiovascular Pharmacology|2025|9
A Systematic Review Of Predictive Models In Acute Heart Failure
|Value in Health|2017|0